In a recent study published in the journal Nature, researchers investigate whether pairs of unrelated B-cells of naive, unswitched, memory and plasmablast phenotypes that have similar heavy chains ...

The ANDROMEDA trial showed improved MOD-PFS and OS with daratumumab and hyaluronidase plus VCd compared to VCd alone in light ...

Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter Study We report 20 years of ...

When Sally Cox was diagnosed with light chain amyloidosis (AL) in 2019, she was shocked. Not only had she never heard of the rare disease that causes abnormal proteins (or amyloids) to build up in ...

Elie Fahed, MD: I was waiting to get my paperwork in order, and you were seeing a local doctor, Dr. Alan Grosset. He was helping you, and he did the bone marrow biopsy and then the MRI. Mark Ayen: He ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted accelerated approval to daratumumab plus hyaluronidase-fihj in combination with bortezomib, ...

New research shows that young adults with obesity already display biological patterns associated with liver stress, chronic inflammation, and early neural injury—changes typically seen in older adults ...

Please provide your email address to receive an email when new articles are posted on . 31 patients, with and without mild cognitive impairment, underwent overnight polysomnogram with blood draw for ...

TORONTO, ON / ACCESSWIRE / April 20, 2020 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, today announced a strategic agreement with Light Chain Bioscience (a brand of ...